Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 229 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2786 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165322
APO-OXYCODONE CR 5.0MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-09-23 165332
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-20 2023-02-09 175312
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-OXYCODONE CR 20.0MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-01-26 177612
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2022-12-16 177672
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179444
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-23 2023-03-02 179447
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-13 2023-04-21 181107
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-09 2023-03-02 184086
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-09 2023-02-23 184100
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-16 2023-05-12 185019
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185967

Showing 2901 to 2920 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
IBUPROFEN CAPLETS 200MG TABLET Discontinued 2019-01-03 2019-01-03 71112
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
ACETAMINOPHEN TABLETS USP 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71216
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222
ACETAMINOPHEN CAPLETS 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71225
NAPROXEN SODIUM TABLETS 220MG TABLET Discontinued 2019-01-04 2019-01-04 71228
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-01-07 71436

Showing 301 to 320 of 356